Recall of Daptomycin for Injection, 500 mg/vial
On August 12, 2020, the U.S. Food and Drug Administration (FDA) announced that Mylan is voluntarily recalling one lot of Daptomycin for Injection, 500 mg/vial as a Class I Recall. Mylan is only recalling one lot of Daptomycin for Injection, 500 mg/vial due to the presence of particulate matter in the vial.
Please note that not all lots are affected, so you may not be affected by this recall. Your health and safety are important to us. If you are currently taking Daptomycin for Injection, 500 mg/vial, please contact your health care provider to discuss which other treatments or medicines made may be appropriate.
For more information, please visit https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-initiates-voluntary-nationwide-recall-one-lot-daptomycin-injection-due-presence-particulate#:~:text=(NASDAQ%3A%20MYL)%20today%20announced,manufactured%20by%20Mylan%20Laboratories%20Limited's. You can also contact Mylan Customer Relations by phone at 1-800-796-9526 (TTY 711), Monday through Friday, 8 a.m. to 5 p.m., Eastern Time (ET) or by email at email@example.com. In addition, you can call the Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016 (TTY 711), Monday through Friday, 8 a.m. to 6:30 p.m., and Saturday 8 a.m. to 4:30 p.m., ET.